Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 25, 1999

View Archived Issues

Corvas continues development progress during third quarter

AHP updates investors and analysts on R&D progress

Idec completes patient enrollment in two pivotal studies during third quarter

Review of Hectorol Injection NDA back on course

Potassium channel activator SKP-450 has potent antiulcer effects in rat models

Three-year subdermal contraceptive implant marketed in the U.K.

Sanofi-Synthelabo's platinum complex launched in second European market

Wound-healing agent reaches the market in U.K.

Creative BioMolecules funnels resources towards stroke and renal disease therapy

Polyethoxylated retinamides superior to known retinoic acid derivatives for skin aging

Interim phase I/II results presented for Transgene's TG-1021

Preclinical results indicate that nefiracetam may have anticonvulsant effects

News from AAO/PAAO joint meeting: droperidol may be indicated for glaucoma

Cancer immunotherapy method available for licensing from NIH

Alphagan safely and effectively lowers IOP in glaucoma patients

Specific FKBP-12 rotamase inhibitors useful for neurodegenerative disorders

Nonpeptide integrin antagonists from DuPont and use for inhibiting cell adhesion

AHP's new beta3-adrenoceptor agonists presented in patent literature

HepaVec and CSIRO sign option agreement for ovine viral vector technology

New anticoagulants in the pipeline at DuPont

U. of Minnesota designs anticancer, antiviral phosphoramidated nucleosides

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...